Study into conolidine has resulted in discovery of an opioid receptor in the human body referred to as ACKR3/CXCR7. ACKR3 seems to be essentially the most popular target for conolidine, which also disregards the opposite 4 classical opioid receptors(three).Advances while in the knowledge of the mobile and molecular mechanisms of pain and the traits